SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-305194
Filing Date
2023-12-28
Accepted
2023-12-28 16:47:47
Documents
12
Period of Report
2023-12-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d607811d8k.htm   iXBRL 8-K 21487
  Complete submission text file 0001193125-23-305194.txt   146047

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aclx-20231228.xsd EX-101.SCH 2840
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aclx-20231228_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aclx-20231228_pre.xml EX-101.PRE 11701
6 EXTRACTED XBRL INSTANCE DOCUMENT d607811d8k_htm.xml XML 3467
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

IRS No.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 231523224
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)